ğŸ‘ å°åˆ†å­|æ–°å† ç—…æ¯’3CLéå…±ä»·æŠ‘åˆ¶å‰‚ML300è¡ç”Ÿç‰©çš„ç»“æ„ä¼˜åŒ–

---
[TOC]

---


## å‚è€ƒæ–‡çŒ®
1. Han S H, Goins C M, Arya T, et al. Structure-based optimization of ML300-derived, noncovalent inhibitors targeting the severe acute respiratory syndrome coronavirus 3CL protease (SARS-CoV-2 3CLpro)[J]. Journal of Medicinal Chemistry, 2021, 65(4): 2880-2904. 